US Personalized Medicine Market Research Report- Forecast to 2030

U.S. Personalized Medicine Market Research Report Information, by product (diagnostic, therapeutics, medical care and nutrition and wellness) by application (diagnosis and intervention, drug development and usage, cancer genomics and others), by End users (hospitals, molecular diagnostic laboratories and testing centers, academic institutes, bio and health informatics companies and others)- Forecast to 2030

ID: MRFR/Pharma/10195-HCR | 85 Pages | Author: Garvit Vyas | February 2024         

Table Of Contents

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5 U.S. PERSONALISED MEDICINE MARKET, BY PRODUCT

5.1 DIAGNOSTIC

5.2 THERAPEUTICS

5.3 MEDICAL CARE

5.4 NUTRITION AND WELLNESS

5.5 OTHERS

6. U.S. PERSONALISED MEDICINE MARKET, BY APPLICATION

6.1 DIAGNOSIS AND INTERVENTION

6.3 DRUG DEVELOPMENT AND USAGE

6.4 CANCER GENOMICS

6.5 OTHERS

7. U.S. PERSONALISED MEDICINE MARKET, BY END USERS

7.1 HOSPITALS

7.2 MOLECULAR DIAGNOSTIC LABORATORIES AND TESTING CENTERS

7.3 ACADEMIC INSTITUTES

7.4 BIO AND HEALTH INFORMATICS COMPANIES

7.4 OTHERS

8. U.S. PERSONALISED MEDICINE MARKET, BY REGION

8.1 U.S.

8.1.1 INTRODUCTION

9. COMPETITIVE LANDSCAPE

9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS

9..1.1 STRATEGIC PARTNERSHIP

9..1.2 MERGER & ACQUISITION

10 COMPANY PROFILE

10.1 ABBOTT

10.1.1 OVERVIEW

10.1.2 PRODUCT OVERVIEW

10.1.3 FINANCIALS

10.1.4 KEY DEVELOPMENTS

10.2 BECTON DICKINSON & CO.,

10.2.1 OVERVIEW

10.2.2 PRODUCT OVERVIEW

10.2.3 FINANCIALS

10.2.4 KEY DEVELOPMENTS

10.3 GE HEALTHCARE

10.3.1 OVERVIEW

10.3.2 PRODUCT OVERVIEW

10.3.3 FINANCIALS

10.3.4 STRATEGY

10.3.5 KEY DEVELOPMENT

10.4 LABORATORY CORPORATION OF AMERICA

10.4.1 OVERVIEW

10.4.2 PRODUCT OVERVIEW

10.4.3 FINANCIALS

10.4.4 KEY DEVELOPMENTS

10.5 PFIZER

10.5.1 OVERVIEW

10.5.2 PRODUCT OVERVIEW

10.5.3 FINANCIALS

10.5.4 KEY DEVELOPMENTS

10.6 OTHERS

List Of Tables

TABLE 1 U.S. PERSONALISED MEDICINE MARKET, BY PRODUCT, 2020-2027 (USD MILLION)

TABLE 2 U.S. PERSONALISED MEDICINE MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 3 U.S. PERSONALISED MEDICINE MARKETBY END USERS 2020-2027 (USD MILLION)

TABLE 4 U.S. PERSONALISED MEDICINE MARKET, BY REGION 2020-2027 (USD MILLION)

List Of Figures

FIGURE 1 RESEARCH PROCESS

FIGURE 2 PORTERS FIVE FORCES MODEL

FIGURE 3 U.S. PERSONALISED MEDICINE MARKET, BY PRODUCT

FIGURE 4 U.S. PERSONALISED MEDICINE MARKET, BY APPLICATION

FIGURE 5 U.S. PERSONALISED MEDICINE MARKET, BY END USERS

FIGURE 6 U.S. PERSONALISED MEDICINE MARKET, BY REGION

FIGURE 7 U.S. PERSONALISED MEDICINE MARKET: COMPANY SHARE ANALYSIS, 2020

Leading companies partner with us for data-driven Insights.
Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid